CAS 143257-98-1: Lerisetron
Description:Lerisetron is a chemical compound classified as a selective serotonin receptor antagonist, specifically targeting the 5-HT3 receptor. It is primarily investigated for its potential use in the treatment of gastrointestinal disorders, particularly those associated with nausea and vomiting, such as chemotherapy-induced nausea. The compound exhibits a high affinity for the 5-HT3 receptor, which plays a crucial role in the emetic response. Lerisetron's mechanism of action involves blocking serotonin's effects at these receptors, thereby reducing the sensation of nausea. In terms of its physical properties, Lerisetron is typically presented as a white to off-white solid, and its solubility characteristics allow for formulation in various pharmaceutical preparations. As with many pharmacological agents, the safety and efficacy profile of Lerisetron is evaluated through clinical trials, and it is essential to consider potential side effects and interactions with other medications. Overall, Lerisetron represents a significant area of research in the field of antiemetic therapies.
Formula:C18H20N4
InChI:InChI=1S/C18H20N4/c1-2-6-15(7-3-1)14-22-17-9-5-4-8-16(17)20-18(22)21-12-10-19-11-13-21/h1-9,19H,10-14H2
InChI key:InChIKey=PWWDCRQZITYKDV-UHFFFAOYSA-N
SMILES:N=1C=2C=CC=CC2N(C1N3CCNCC3)CC=4C=CC=CC4
- Synonyms:
- 1-(Phenylmethyl)-2-(1-piperazinyl)-1H-benzimidazole
- 1-Benzyl-2-(1-piperazinyl)benzimidazole
- 1-Benzyl-2-(piperazin-1-yl)-1H-1,3-benzodiazole
- 1-benzyl-2-(piperazin-1-yl)-1H-benzimidazole
- 1H-Benzimidazole, 1-(phenylmethyl)-2-(1-piperazinyl)-
- Lerisetron [INN]
- Unii-Q36R82Sxrg
- Lerisetron
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Lerisetron REF: IN-DA009HVFCAS: 143257-98-1 | 99% | To inquire | Thu 27 Mar 25 |
![]() | Lerisetron REF: TM-T8441CAS: 143257-98-1 | 99.15% | 66.00 €~700.00 € | Thu 03 Apr 25 |
![]() | 1-Benzyl-2-(piperazin-1-yl)-1H-1,3-benzodiazole REF: 3D-TFA25798CAS: 143257-98-1 | Min. 95% | To inquire | Thu 08 May 25 |
![]() | 1-benzyl-2-piperazin-1-yl-1H-benzimidazole dihydrochloride REF: 10-F511895CAS: 143257-98-1 | 95.0% | - - - | Discontinued product |

Lerisetron
Ref: TM-T8441
1mg | 66.00 € | ||
5mg | 127.00 € | ||
10mg | 188.00 € | ||
25mg | 331.00 € | ||
50mg | 487.00 € | ||
100mg | 700.00 € | ||
1mL*10mM (DMSO) | 124.00 € |

1-Benzyl-2-(piperazin-1-yl)-1H-1,3-benzodiazole
Ref: 3D-TFA25798
50mg | 497.00 € | ||
500mg | 1,360.00 € |

1-benzyl-2-piperazin-1-yl-1H-benzimidazole dihydrochloride
Ref: 10-F511895
1g | Discontinued | Request information | |
2.5g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |